Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2’,2’‐difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer

The aim of this work is to build a mechanistic multiscale pharmacokinetic model for the anticancer drug 2’,2’‐difluorodeoxycytidine (gemcitabine, dFdC), able to describe the concentrations of dFdC metabolites in the pancreatic tumor tissue in dependence of physiological and genetic patient character...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia‐Cremades, Maria, Melillo, Nicola, Troconiz, Iñaki F., Magni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214642/
https://www.ncbi.nlm.nih.gov/pubmed/32043298
http://dx.doi.org/10.1111/cts.12747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214642/
https://www.ncbi.nlm.nih.gov/pubmed/32043298
http://dx.doi.org/10.1111/cts.12747

Ejemplares similares